CD274 and neoplasm: Recent research has focused on the tumour mutation burden, interferon-γ gene signature and tumour immune status on the basis of PD-L1 expression and CD8+TILs as representative predictive candidates of immunotherapy.14,37,45 However, invasive tumour tissue sampling is warranted to analyse the protein expression and extract the DNA and RNA derived from tumour tissues.